Domain Partners VI, L.P. is 10% at CADENCE PHARMACEUTICALS INC (CADX). They have made 4 open-market trades across 4 companies since 2010, most recently 2016-09-09.
CIK 0001348649
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $12.5M since 2010, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MRNS | BUY | 2014-08-05 | 2014-08-07 | $8.00 | $3.4M | -21.7% | -3.2% | -3.2% |
| RGDO | BUY | 2013-08-27 | 2013-08-28 | $4.00 | $3.0M | N/A | N/A | N/A |
| OCRX | BUY | 2013-07-15 | 2013-07-31 | $6.03 | $2.0M | N/A | N/A | N/A |
| ALIM | SELL · 10b5-1 | 2013-06-14 | 2013-06-18 | $5.29 | $670K | -20.2% | +0.0% | +0.0% |
| CADX | SELL · 10b5-1 | 2013-03-05 | 2013-03-07 | $5.03 | $122K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-02-15 | 2013-02-20 | $5.02 | $202K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-01-28 | 2013-01-30 | $5.34 | $526K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-01-24 | 2013-01-29 | $5.43 | $839K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-01-17 | 2013-01-22 | $5.25 | $514K | N/A | N/A | N/A |
| ALIM | BUY | 2010-04-27 | 2010-04-27 | $11.00 | $4.2M | -20.2% | +0.0% | +0.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| OCRX |
| 1,857,036 |
| — |
| CADX | 7,698,480 | — |
| Total | $121.8M |
Shares reported on the most recent Form 4, priced at the 2016-08-03 close. 4 holdings could not be priced and are excluded from the total.